Thrivent Financial for Lutherans’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.35M Hold
12,633
﹤0.01% 1815
2026
Q1
$2.07M Buy
+12,633
New +$1.94M ﹤0.01% 1419
2025
Q4
Sell
-4,487
Closed -$646K 2607
2025
Q3
$646K Sell
4,487
-4,070
-48% -$499K ﹤0.01% 1982
2025
Q2
$861K Buy
+8,557
New +$654K ﹤0.01% 1877
2023
Q2
Sell
-163,160
Closed -$2.78M 2498
2023
Q1
$2.78M Buy
+163,160
New +$3.17M 0.01% 1078
2021
Q1
Sell
-36,230
Closed -$1.21M 2545
2020
Q4
$1.21M Hold
36,230
﹤0.01% 1627
2020
Q3
$1.16M Sell
36,230
-34
-0.1% -$977 ﹤0.01% 1478
2020
Q2
$999K Hold
36,264
﹤0.01% 1488
2020
Q1
$581K Buy
+36,264
New +$860K ﹤0.01% 1632

Other funds holding INSM

Thrivent Financial for Lutherans's INSM Position: Q2 2026 in Review

Thrivent Financial for Lutherans held its Insmed (INSM) position steady in Q2 2026 at 12,633 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1815.

Thrivent Financial for Lutherans first reported a position in INSM in Q1 2020 and has held it in 9 quarters since. The position peaked at $2.78M in Q1 2023. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Thrivent Financial for Lutherans held 12,633 shares of Insmed worth $1.35M as of Q2 2026.
  • Thrivent Financial for Lutherans left its Insmed share count unchanged in Q2 2026.
  • Insmed made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #1815 holding.
  • Thrivent Financial for Lutherans first reported a position in Insmed in Q1 2020 and has held it in 9 quarters since.
  • Thrivent Financial for Lutherans's Insmed position peaked at $2.78M in Q1 2023.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.